SCHEMBL7828011

SCHEMBL7828011

Cc1ccc(C(C#N)C2CCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.58
CHRM2 P08172 3/20 0.42
CHRM1 P11229 3/20 0.42
CHRM4 P08173 2/20 0.42
CHRM3 P20309 2/20 0.42
FPR2 P25090 1/20 0.38
PROKR1 Q8TCW9 1/20 0.38
HTR1E P28566 1/20 0.37
S1PR3 Q99500 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 5/20 0.35
GAA P10253 1/20 0.35
CYP2A6 P11509 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10963570 0.84 SLC6A3 (0.43) SLC6A3FPR2PROKR1MEN1KMT2A
SCHEMBL7956279 0.81 SLC6A3 (0.58) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL7512949 0.81 SLC6A3 (0.58) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL961019 0.81 SLC6A3 (0.57) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL4246228 0.81 CHRM2 (0.60) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL7236223 0.80 SLC6A3 (0.59) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL7840990 0.80 SLC6A3 (0.56) SLC6A3ALDH1A1GAASMN1; SMN2NPC1
SCHEMBL959762 0.79 SLC6A3 (0.58) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL13124077 0.79 SLC6A3 (0.58) SLC6A3CHRM2CHRM1CHRM4CHRM3
SCHEMBL17892330 0.79 SLC6A3 (0.55) SLC6A3CHRM2CHRM1CHRM4CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513533-B1 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application BAYER AG (DE) 2001-11-21 EP disclosed
EP-1127880-A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation BAYER AG (DE) 2001-08-29 EP disclosed
US-5776964-A HYPOTENSIVE AGENTS; ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5521206-A HYPOTENSIVE AGENTS, TREATMENT OF ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed
CN-1031339-C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments BAYER AG (DE) 1996-03-20 CN disclosed
EP-0513533-A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application BAYER AG (DE) 1992-11-19 EP disclosed
CN-1066065-A The phenylacetic acid derivatives of heterocyclic substituted and method for making thereof and pharmaceutical use BAYER AG (DE) 1992-11-11 CN disclosed